Tigecycline in the treatment of ventilator-associated pneumonia: Experience from the Latin American tigecycline use registry

Infezioni in Medicina

Volumn 18, Issue 1, 2010, Pages 27-34

  Curcio, Daniel ^a,b,c,d,e   Castagnino, Jorge ^b   Vazquez, Walter ^c   Vergara, Gabriel ^d   Curiale, Ariel ^e  

^a Instituto Sacre Cour   (Argentina)

^b Sanatorio de la Providencia   (Argentina)

^c HOSPITAL ESPAÑOL DE MENDOZA   (Argentina)

^d HOSPITAL RAMOS MEJÍA   (Argentina)

^e ClinicalREC   (Argentina)

Author keywords

Multidrug resistant pathogens; Tigecycline; Ventilator associated pneumonia

Indexed keywords

CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TIGECYCLINE; VANCOMYCIN;

ACINETOBACTER; ADULT; AGED; ARGENTINA; ARTICLE; BACTEREMIA; BLOOD CULTURE; CONTROLLED STUDY; DISEASE REGISTRY; FEMALE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; PHYSICIAN; SOUTH AND CENTRAL AMERICA; VENTILATOR ASSOCIATED PNEUMONIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; DRUG EVALUATION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG UTILIZATION; FEMALE; HOSPITAL MORTALITY; HOSPITAL RECORDS; HUMANS; INTENSIVE CARE UNITS; LATIN AMERICA; MALE; MIDDLE AGED; MINOCYCLINE; PNEUMONIA, VENTILATOR-ASSOCIATED; PROSPECTIVE STUDIES; REGISTRIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77951618976     PISSN: 11249390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Masterton R.G., Galloway A., French G., et al. Guidelines for the management of hospital-acquired pneumonia in the UK: report of the working party on hospital-acquired pneumonia of the British Society for Antimicrobial Chemotherapy. J. Antimicrob. Chemother. 62, 5-34, 2008.
2. American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am. J. Respir. Crit. Care Med. 171, 388-416, 2005.
3. Pankey G.A. Tigecycline. J. Antimicrob. Chemother. 56, 470-480, 2005.
4. http://www.accessdata.fda.gov/drugsatfda-docs/label/ (last access June 20, 2009).
5. Curcio D., Fernández F., Duret F. Initial use of tigecycline in Argentina. Rev. Chilena Infectol. 24, 497-499, 2007.
6. Curcio D., Fernández F., Cané A., et al. Indications of a new antibiotic in clinical practice: results of the tigecycline initial use registry. Braz. J. Infect. Dis. 12, 198-201, 2008.
7. Garner J.S., Jarvis W.R., Emori T.G., Horan T.C., Hughes J.M. CDC definitions for nosocomial infections, 1988. Am. J. Infect. Control 16, 28-40, 1988.
8. Krieg N.R., Holt J.G. Bergey's Manual of systematic bacteriology, Volume 1. Baltimore, MD, USA: Williams & Wilkins, 1984.
9. Clinical and Laboratory Standard Institute, Wayne, PA. CLSI document. 2007. Clinical and Laboratory Standard Methods. Performance standards for antimicrobial susceptibility testing: seventeenth informational supplement; p. M100-S17.
10. Clinical and Laboratory Standards Institute. 2007. M100-S17: performance standards for antimicrobial susceptibility testing, 17th informational supplement. CLSI, Wayne, PA.
11. Schafer J.J., Goff D.A., Stevenson K.B., et al. Early experience with tigecycline for ventilator-associated pneumonia and bacteremia caused by multidrug-resistant Acinetobacter baumannii. Pharmacotherapy 27, 980-987, 2007.
12. Curcio D., Fernández F., Vergara J., et al. Late onset ventilator-associated pneumonia due to multidrug-resistant Acinetobacter spp.: experience with tigecycline. J. Chemother. 21, 58-62, 2009.
13. Poulakou G., Kontopidou F.V., Paramythiotou E. Tigecycline in the treatment of infections from multi-drug resistant gram-negative pathogens. Journal of Infection 58, 273-284, 2009.
14. Cuthbertson B.H., Thompson M., Sherry A., et al. Antibiotic-treated infections in intensive care patients in the UK. Anaesthesia 59, 885-890, 2004. (Pubitemid 39214389)
15. Heyland D.K., Cook D.J., Griffith L., et al. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. Am. J. Respir. Crit. Care Med. 159, 1249-1256, 1999.